cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor
Molecular Psychiatry2016Vol. 22(5), pp. 754–759
Citations Over TimeTop 10% of 2016 papers
Masahiro Fujita, Erica M. Richards, Mark J. Niciu, D. Ionescu, Sami S. Zoghbi, Jau‐Shyong Hong, Sanjay Telu, Christina S. Hines, Victor W. Pike, Carlos A. Zarate, Robert B. Innis
Related Papers
- → Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: A retest study and use of an image-derived input function(2010)34 cited
- → Chapter 2 Recent Developments in Monoamine Reuptake Inhibitors(2007)22 cited
- → Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors(2013)9 cited
- → Development of norepinephrine transporter reuptake inhibition assays using SK-N-BE(2)C cells(2018)3 cited
- Syntheses and Evaluation of Phosphodiesterase Subtype 4D (PDE4D) PET Radioligand Candidates in Monkey(2020)